Filtered news list testing
List of Reports
.pdf
07/26/2018 - Revenue at 2nd quarter 2018
.pdf
06/30/2018 - Financial report : First half 2018
.pdf
06/30/2018 - Financial report : First half 2018
.pdf
04/26/2018 - Registration document 2017
.pdf
04/18/2018 - GEAR 2023 strategic plan (press release)
.pdf
04/18/2018 - Revenue at 1st quarter 2018
.pdf
04/18/2018 - Guerbet Launches GEAR 2023 (presentation)
.pdf
03/28/2018 - Annual results 2017 (presentation)
Single report testing
.pdf
test report fabien V 09-07
Separator
Filtered images
Discover the latest news of Guerbet
Latest news
U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT
U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT
2024 revenue
2024 revenue
Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging
Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging